Intensive Therapy Archival Research

September 4, 2017 updated by: Trauma Institute & Child Trauma Institute
This is an internal treatment evaluation to determine whether eye movement desensitization and reprocessing (EMDR) or progressive counting (PC) should become the preferred trauma treatment for the investigator's clients. The investigator is using routine/existing in-house measures and case files to track symptom reduction, trauma treatment time, rate of treatment switching (from EMDR to PC or vice versa), and rate of trauma treatment refusal. This is retrospective as well as prospective archival research.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Northampton, Massachusetts, United States, 01060
        • Recruiting
        • Trauma Institute & Child Trauma Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All participants in the Trauma Institute & Child Trauma Institute Victims of Crime program will be included.

Description

Inclusion Criteria:

  • Victims of crimes, including assault, rape, robbery, intimate partner violence, child abuse, kidnapping, vehicular homicide, and suicide
  • Witnesses and family members of victims

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adult victims of sexual assault
Eye movement desensitization and reprocessing (intensive format)
Progressive counting (intensive format)
Children who have been exposed to domestic abuse
Eye movement desensitization and reprocessing (intensive format)
Progressive counting (intensive format)
Women with perinatal emotional complications
Eye movement desensitization and reprocessing (intensive format)
Progressive counting (intensive format)
Teens with behavior problems and histories of abuse
Eye movement desensitization and reprocessing (intensive format)
Progressive counting (intensive format)
Veterans with military-related trauma
Eye movement desensitization and reprocessing (intensive format)
Progressive counting (intensive format)
Survivors of intimate partner violence
Eye movement desensitization and reprocessing (intensive format)
Progressive counting (intensive format)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PRS following treatment
Time Frame: Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Problem Rating Scale
Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Change in TSI-2 following treatment
Time Frame: Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Trauma Symptom Inventory-2
Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Change in TSCC following treatment
Time Frame: Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment
Trauma Symptom Checklist for Children
Administered pre-treatment, two weeks post-treatment, and 12 weeks post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2017

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

December 31, 2022

Study Registration Dates

First Submitted

August 31, 2017

First Submitted That Met QC Criteria

August 31, 2017

First Posted (Actual)

September 5, 2017

Study Record Updates

Last Update Posted (Actual)

September 7, 2017

Last Update Submitted That Met QC Criteria

September 4, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2017-1001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma, Psychological

Clinical Trials on EMDR

Subscribe